FDA Approved: DULOXETINE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approves a supplemental application for a generic duloxetine from Zydus Lifesciences Limited, authorizing marketing of the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Fibromyalgia
• Generalized Anxiety Disorder
• Major Depressive Disorder
• Musculoskeletal Pain

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

SUPPL AP for DULOXETINE (DULOXETINE)